Clinical Trials
Sep 08, 2026 · 1 min read · 15,870 views
Makary pushes for IRB reforms to catch China's speedy trial starts
N
Noah Patel
Editorial · Sep 08, 2026
Reports indicate that the process by which institutional review boards oversee clinical trials needs reforms that are "big and different" so that the US can keep pace with China, FDA Commissioner Marty
← Previous
Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins
Next →
FDA should require credentials for psychedelic providers, experts say
